Rekha Chaudhuri, Charles McSharry, Mark Spears, Jeffrey Brady, Christal Grierson, C Martina Messow, Gino Miele, Karl Nocka, William MacNee, Martin Connell, John T Murchison, Michael Sproule, Omar Hilmi, Douglas K Miller, Neil C Thomson
BACKGROUND: Matrix-metalloproteinase (MMP)-9 has been implicated in the pathogenesis of COPD, although its link to disease severity is unclear. The purpose of the study was to examine the relationship between disease severity assessed by lung function and computed tomography (CT) and sputum MMP-9 expression, concentration and activity in patients with COPD. FINDINGS: In 53 COPD subjects, smokers and ex-smokers; 46 healthy controls, smokers and never smokers, we measured sputum MMP-9 concentrations (ELISA) and enzyme activity (FRET), sputum MMP-9 mRNA expression, spirometry, diffusing capacity for carbon monoxide (DLco) and CT assessment of emphysema (% low attenuation areas below-950 Hounsfield units)...
December 2013: Translational Respiratory Medicine